Why won’t GSK pay compensation in the UK?

I’ve asked this before, but the question is still very relevant – you see, the thing is, GSK has paid out millions in compensation to patients (and their children) in the USA who have been damaged by Seroxat/Paxil – but not a penny in the UK… I’m confused, is GSK admitting Paxil is a dangerous drug in America with the potential for terrible side effects, but saying Seroxat in the UK is completely safe and not dangerous at all?

And there’s me, thinking they were the same pills!

But of course, the answer to the question “Why not pay compensation in the UK as well?” has nothing to do with drug safety or patients’ suffering and everything to do with profits and business.

In the USA cases like this are heard before juries and lawyers will take cases on a ‘no win, no fee’ basis and settlements can be very high, so the drug companies are running scared. Because of this, most cases in the USA are settled out of court and Confidentiality Agreements ensure none of the truth ever comes to light (see below).

However, in the UK, cases are heard before a single High Court Judge, any settlements would be much lower than in America and funding is much harder to find – certainly Legal Aid is no longer an option in 2016.

So in the UK, GSK might use a legal firm, perhaps like Addleshaw Goddard, to obfuscate and ensure litigation drags out for years and years, to the point where many claimants just give up or are scared off or the momentum of the case simply grinds to halt – it’s a war of attrition and has nothing to do with justice or patient safety.

Behind the scenes it seems there are other pressures that can be brought to bear to ensure that big business has a better chance of winning. Business and government are far too close – but more of that on another day.

Certainly,this has been going on far too long in the UK – I wrote this in 2009 (and 2007):  Given the fact that Glaxo is currently on trial in Philadelphia (and will be in the High Court in London next year), [sic] I thought this repost (from March 2007) might of interest to you.

Drug companies usually favour the out of court settlement – they don’t like the public scrutiny that court cases bring – not to mention the previously secret information that all too often comes to light.

But along with the settlement comes the confidentiality ‘agreement’. The message the drug companies send out is “we pay up – you shut up” – while all the while never admitting any blame (for anything).

I’m not sure – are Glaxo admitting they’re settling Paxil (Seroxat) cases in the USA?

Well they are – this download – Glaxo settlement agreement – tells its own story, I guess. Pay particular attention to section 3 – Confidentiality of Settlement…

What I find ironic is that Glaxo, being an English company, is prepared to open its cheque book in America, but not in the UK.

So then, Glaxo:

Why won’t you settle in the UK?

Why won’t you help the thousands of people in the UK who have suffered because of Seroxat?

Haven’t you made enough money from the drug?

Why are we having to slug it out with you in the High Court?

Links to the Philadelphia trial details are herehere and here.

This from Seroxat Sufferers details some of the settlements GSK has made in the USA:

…since 2002 GSK have paid out compensation to victims of Seroxat, including over 3,000 people who became addicted to Seroxat, over 800 women whose children were born with serious heart defects because of Seroxat, and also being found guilty of Seroxat causing, in part, the death of Donald Schell and his family members.

And just to underline how GSK does business here are a few links from a Google search for ‘GSK fines’:

2016…

Happy new year to you all – here’s to a big 2016… and who knows what might happen in the next 12 months!

As ever, this time of the year prompts one to reflect on the past – and also to think about the future – and generally just have a bit of a ramble which is what this is.

I don’t really use Facebook very much but I have seen a group there – Paroxetine Paxil Seroxat Withdrawal – which seems to be a very supportive community and I would suggest you take a look if you haven’t already.

Two things stood out for me while reading the posts on the group’s page.

Firstly, it really is beyond belief that Doctors are STILL prescribing Seroxat/Paxil in 2016. Surely by now, Docs around the world should be aware of all the problems surrounding Seroxat. Glaxo’s manipulation of the drug trials and the way the company hid negative data is no longer a secret – have a look here  and here

Secondly, it seems that healthcare ‘professionals’ have little or no idea how to advise the best way to withdraw from Seroxat. Again, in 2016, there is no excuse for this – neither is there an excuse for any Doctor to deny that patients may well suffer from terrible problems when they try to stop taking Seroxat.

Of course, Glaxo has (in)famously never offered any kind of meaningful withdrawal advice – to do so would be an admission that there is a huge problem with Seroxat… and that would would be bad for business. And we can’t have that, can we?

When I withdrew, I used the 10% rule (and liquid Seroxat) – I never reduced by more than 10% of my current dose and I stabilised for a long time between reductions, waiting until I felt strong enough to try the next reduction. I never put any time limit on the process, rather kept telling myself at least I was moving forward, no matter how slowly. It took me 22 months to stop completely and then a few years

I’ve been writing this blog for quite a while now, so apologies as I’ve just noticed some links in my posts have ‘died’ over the course of the years – I still like to think there’s a lot of good info available here on Seroxat Secrets.

So, deep breath, here we go – it’s another year coming up!

A history of SSRIs

This is a re-post from something I wrote in March 2007 – on reflection, perhaps it should be more accurately entitled A History of SSRIs and the Damage they do to Patients.

I think there may well be a lot of discussion in the coming months about Seroxat dependency and the terrible withdrawal symptoms that many people have to endure as they try to stop taking Seroxat and so I think that the download – A History of SSRIs  is more relevant today than ever.

Looking at my original post, I was remiss as I didn’t credit the author of the download – so belated apologies to Prof David Healy (I think it’s his piece).

Now read on:

Over the years I have collected a few interesting documents and I think it’s just plain selfish to keep them to myself so I’m starting to share them with you.

The one for download here – A History of SSRIs is exactly what it says it is… a history of SSRIs.

You can read about the first SSRI – Zelmid – which was patented in 1972 and made it to market in 1982 before any of the others. I suppose not many of you remember Zelmid though as it was discovered in rare cases to cause a serious neurological disorder called Guillain-Barré Syndrome. This potentially fatal disorder led to the immediate removal of the drug from the market.

But Astra had already begun the development of a derivative of Zelmid, called alaproclate, when Zelmid ran into trouble. Alaproclate was being investigated for both depression and Alzheimer’s disease. But it caused liver problems in one strain of laboratory mice and this was enough to lead Astra to drop it. Shortly after this, Astra introduced an innovative antipsychotic, remoxipride, which looked like it would have significantly fewer side effects than older agents. Several months after its launch, however, remoxipride was reported to cause aplastic anemia in a small number of people and it too was withdrawn.

Notice a pattern here?

And did you know this about Prozac? As Eli Lilly were trying to launch Prozac in Germany they came up against a slight problem with the view of the German regulators on fluoxetine (Prozac) as of May 1984: “Considering the benefit and the risk, we think this preparation totally unsuitable for the treatment of depression”.

A History of SSRIs is an enlightening document – with a large section on Seroxat…

 

 

What I believe

I believe Seroxat is defective and dangerous.

I believe that Glaxo has hidden clinical trial data that shows exactly how dangerous a drug it is.

I believe that Seroxat is addictive.

I believe that Seroxat can cause anger, aggression and violence.

I believe that something must be done to help people who suffer terrible problems with withdrawal, as they desperately try to stop taking Seroxat.

I believe that doctors have taken large sums of money from Glaxo to lie about the efficacy and safety of the drug.

I believe that GlaxoSmithKline puts profits before patients – their wealth before our health.

I took Seroxat for 9 years and it took me 22 months to withdraw from the drug little by little.

Believe me – I know what I’m talking about.

RxISK – Making medicines safer for all of us

This is good.

Here’s a new website that Prof David Healy’s involved with. RxISK is a free, independent drug safety website where you can research a prescription drug to see what side effects have been reported and also share your experience and get a free RxISK Report to take to your doctor if need be.

This from RxISK:

A Good Drug is a chemical + Good Information. Most of the information on what drugs actually do is missing. Only you can provide it. Using RxISK will tell you more about the drugs you are prescribed than anything else will. By reporting to RxISK you can help make Good Drugs. Less than 5% of drug side effects are reported. Your voice has been silenced – globally.

Little is known about the effects of drugs on our hair, sex and relationships, violent and other extreme acts or thoughts, and our skin and nails, because these effects are not considered medically significant and are not tracked.

We have created the RxISK Zones with two purposes in mind:

  1. To enable you to easily search for prescription drug side effects on hair, sex, violence, suicide, and other aspects of our every day lives in the more than three million adverse drug event reports filed with the FDA since 2004, as well as our expanding RxISK database.
  2. To make it even easier for you to report these types of prescription drug side effects on RxISK.org and with your country’s drug regulator or the FDA if we don’t yet have your country’s form.

Just imagine — by reporting your experiences, you can help make RxISK the most comprehensive source of independent information on drug side effects in these important personal areas.

How it works

At the bottom of any Zone page, simply enter a prescription drug and click Continue. On the following summary page, check the box next to any side effect you are experiencing, and click the Report a drug side effect button to quickly create your personalized RxISK Report with your RxISK Score to take to your health care professional to help them help you.

The page is here if you want to add to the real world knowledge available about the drugs you take.

Seroxat litigation in the UK – important news

The High Court action against Glaxo isn’t quite over.

There were 500 litigants to start with. This number dropped to about 150.

These 150 people received a letter recently.

And today, I have been sent a copy of this email:

Hi All, If you haven’t already, please can you get in touch with Sarah-Jane Richards at Secure Law to confirm you want to continue in the action and you are happy for her to represent you.  You need to do this and previous correspondence will not count as this involves the instruction of a new law firm…we really need strength in numbers.  Please can you also confirm if you are happy for your email to be added to her list and advise if you are still taking Seroxat and if you are on benefits.

If you’ve got the letter, you’ve got the link.

Use it.

Should we trust GlaxoSmithKline – and Andrew Witty…?

Trust GlaxoSmithKline?

Trust GSK? – you must be mad.

Sarah Boseley in The Guardian writes:

“The British drugs company GlaxoSmithKline is to open up the detailed data from its clinical trials to the scrutiny of scientists in a bid to help the discovery of new medicines and end the suspicions of critics that it has secrets to hide.

In a speech today [11 Oct] to the Wellcome Trust in London, the chief executive, Andrew Witty, will say openness to the public and active collaboration with scientists and firms outside GSK are essential to finding new drugs to treat the diseases plaguing the world, from novel antibiotics to cures for malaria and tuberculosis.

He told the Guardian GSK had already done much to advance transparency in clinical research, including publishing a summary of every drug trial – whether a success or not – on its website

Said Sir Mark Walport, director of the Wellcome Trust – “In its commitment towards more openness and collaboration, GSK is setting an example of how the pharmaceutical industry must adapt to help drive forward medical advances. Real breakthroughs do not come out of nowhere, but are borne of scientists sharing their knowledge and learning from each other. GSK’s moves are bold and innovative, a very positive sign of its commitment to tackle some of the greatest health challenges facing the world today.”

But hold on a minute – Dr Ben Goldacre’s not sure about GSK :

“But we should judge drug companies by their actions, not by their promises, especially when similar promises have been made in the past, and then broken.

In 1998 GlaxoWellcome promised to set up a clinical trials register, amidst outcry over withheld trial results. But when the company merged with SKB to create GSK, in 2002, this register was unceremonially deleted from the internet. This tragic story is described in an excellent open access article on this history of attempts to get access to hidden data, by Iain Chalmers.

Then, in 2003, GSK were caught withholding clinical trial data showing that their drug seroxat increases the risk of suicide in young people. As part of the settlement on fraud charges, in the US in 2004, GSK were forced to promise to post all trial results on a public website. But in 2012 GSK paid a new $3bn fine for criminal and civil fraud: this included charges over withholding data on the diabetes drug Avandia, as late as 2007, well after this earlier promise of transparency was made”.

That’s a pretty poor record, I’m sure you’ll agree.

As far as GSK is concerned, talk is cheap and promises are routinely broken with no compunction whatsoever.

 

Follow

Get every new post delivered to your Inbox.

Join 90 other followers

%d bloggers like this: